Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes

Item Type:	Letter
Title:	Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes
Creators Name:	Bohl, S.R. and Dolnik, A. and Jensen, T. and Lang, K.M. and Hackanson, B. and Gaidzik, V.I. and Paschka, P. and Knudsen, S. and Döhner, K. and Döhner, H. and Claus, R. and Lübbert, M. and Bullinger, L.
Keywords:	Acute Myeloid Leukemia, Antineoplastic Antimetabolites, Azacitidine, Decitabine, Gene Expression Profiling, Kaplan-Meier Estimate, Leukemic Gene Expression Regulation, Transcriptome, Treatment Outcome, Tumor Biomarkers, Tumor Suppressor Genes
Source:	Leukemia & Lymphoma
ISSN:	1029-2403
Publisher:	Taylor & Francis
Volume:	58
Number:	9
Page Range:	2264-2267
Date:	2 September 2017
Official Publication:	https://doi.org/10.1080/10428194.2017.1287360
PubMed:	View item in PubMed

Repository Staff Only: item control page